Shanghai Bocimed Pharmaceutical

Bocimed Pharmaceutical is a clinical-stage biotechnology company headquartered in Shanghai, China, specializing in the development of complex formulations and high-end drug delivery systems. The company leverages its proprietary technology platforms to develop a diverse pipeline of improved new drugs (505(b)(2)) and innovative small molecules, primarily focusing on the central nervous system, oncology, and ophthalmology. Bocimed's capabilities span the entire drug development lifecycle, from pharmaceutical research and clinical development to GMP manufacturing. In addition to its internal programs, the company operates as a high-end CRO/CDMO, providing specialized technical services to the global pharmaceutical industry. Its lead programs include treatments for schizophrenia and glaucoma that utilize advanced sustained-release technologies.